ArticleFrontiers in immunology2025

Successful sequential treatment with ofatumumab followed by efgartigimod for refractory autoimmune encephalitis with dual anti-NMDAR and anti-GFAP antibody positivity: first case report.

Xin Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.